Divisas / NMRA
NMRA: Neumora Therapeutics Inc
1.73
USD
0.03
(1.70%)
El tipo de cambio de NMRA de hoy ha cambiado un -1.70%. En este caso, el precio mínimo en el mercado ha alcanzado 1.71, mientras que el máximo ha alcanzado 1.76.
Siga la dinámica de la pareja de divisas Neumora Therapeutics Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NMRA News
- Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00
- Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript
- Neumora (NMRA) Q2 Loss Improves 10%
- Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday - Aon (NYSE:AON), Bel Fuse (NASDAQ:BELFA)
- Neumora Therapeutics soars 68% following InvestingPro’s June Fair Value signal
- Mizuho raises Neumora Therapeutics stock price target on new drug candidate
- H.C. Wainwright reiterates Buy rating on Neumora Therapeutics stock
- Neumora begins phase 1 trial of schizophrenia drug NMRA-861
- NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
- ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
- Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy' - Johnson & Johnson (NYSE:JNJ)
- Neumora Therapeutics shares fall as company adjusts depression drug trials
- Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript
Rango diario
1.71
1.76
Rango anual
0.61
17.19
- Cierres anteriores
- 1.76
- Open
- 1.75
- Bid
- 1.73
- Ask
- 2.03
- Low
- 1.71
- High
- 1.76
- Volumen
- 209
- Cambio diario
- -1.70%
- Cambio mensual
- -7.98%
- Cambio a 6 meses
- 6.79%
- Cambio anual
- -84.64%
31 agosto, domingo